CIK 0001710340
- Non-accelerated filer
- Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371858472
- Phone
- +1 847-787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 4 Open-market sale Chief Financial Officer sold 41,713 shares at an average $16.15 ($673,714)
- 4 Open-market sale Chief Business Officer sold 34,000 shares at an average $14.83 ($504,318)
- 4 Open-market buy 10% owner bought 7,930 shares at $15.82 ($125,484)
- 4 Open-market sale President & CEO sold 210,000 shares at an average $17.11 ($3,592,611)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 102,400 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 10,000 shares at $7.98 ($79,814)
- 4 Open-market buy 10% owner bought 62,070 shares at an average $6.99 ($434,137)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 107,500 shares at an average $4.70 ($504,875)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 7 · 133 filings